Pharmacologic Treatment of COPD: Disparities Between Evidence and Recommendations in GOLD 2023/4

Pharmacologic Treatment of COPD: Disparities Between Evidence and Recommendations in GOLD 2023/4

Saved in:

Bibliographic Details
Main Author:	Samy Suissa
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2025-12-01
Series:	COPD
Online Access:	https://www.tandfonline.com/doi/10.1080/15412555.2025.2517622
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Guidelines for the Pharmacologic Treatment of COPD 2023: Canada versus GOLD
by: Samy Suissa
Published: (2024-12-01)

Triple Inhaler versus Dual Bronchodilator Therapy in COPD: Real-World Effectiveness on Mortality
by: Samy Suissa, et al.
Published: (2022-12-01)

Cost–consequence analysis of COPD treatment according to NICE and GOLD recommendations compared with current clinical practice in the UK
by: Jennifer K Quint, et al.
Published: (2022-06-01)

Effectiveness of Aspirin on Major COPD Outcomes: A Prevalent New-User Design Observational Study
by: Charles Khouri, et al.
Published: (2024-12-01)

Implications of using the GLI-2012, GOLD and Australian COPD-X recommendations in assessing the severity of airflow limitation on spirometry among an Indigenous population with COPD: an Indigenous Australians perspective study
by: Timothy P Howarth, et al.
Published: (2021-01-01)

Traumatic brain injury pharmacological treatment: recommendations
by: Renato Anghinah, et al.

Risk Factors of Poor Prognosis after Whiplash Injury
by: Samy Suissa
Published: (2003-01-01)

Pharmacological interventions for patients with chronic primary musculoskeletal pain: disparity between synthesized evidence and real-world clinical practice
by: Helen Koechlin, et al.
Published: (2025-02-01)

ASSESSMENT OF COPD MANAGEMENT COMPLIANCE WITH GOLD 2024 REQUIREMENTS IN POLTAVA REGION
by: V.V. Bilko, et al.
Published: (2024-07-01)

Prompt versus Delayed Triple Therapy in COPD: Solutions to Time-Related Biases in Observational Studies
by: Suissa S, et al.
Published: (2025-07-01)

Editorial: Insight in pharmacological treatment of pain – 2023
by: Robert Gyula Almasi, et al.
Published: (2025-08-01)

Comparison of STAR and GOLD in Assessing Disease Severity Among High-Risk and COPD Patients: Evidence from Enjoying Breathing Program in China
by: Huang K, et al.
Published: (2024-12-01)

Editorial: Insight in non-pharmacological treatment of pain—2023
by: Geoffrey Dover, et al.
Published: (2024-12-01)

Underutilization of palliative care in advanced COPD and heart failure: associations, disparities, and the role of specialists
by: Lior Zornitzki, et al.
Published: (2025-08-01)

A 7-point evidence-based care discharge protocol for patients hospitalized for exacerbation of COPD: consensus strategy and expert recommendation
by: Sundeep Salvi, et al.
Published: (2024-12-01)

NON-PHARMACOLOGICAL THERAPY FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): A SYSTEMATIC REVIEW
by: Nurul Imam, et al.
Published: (2025-04-01)

Updated international recommendations (EULAR, 2023) for the treatment of psoriatic arthritis
by: Yu. L. Korsakova, et al.
Published: (2024-11-01)

Impact of Clinical Pharmacological Intervention on Treatment Adherence among Adult Patients with Bronchial Asthma and COPD: A Randomised Clinical Study
by: Agnik Pal, et al.
Published: (2025-06-01)

Analysis of the Content and Recommendations for the Application of FSBU 4/2023 “Accounting (Financial) Reporting”
by: V. S. Zaika
Published: (2024-11-01)

Integrated network pharmacology, molecular docking, and animal experiments to reveal the potential mechanism of hesperetin on COPD
by: Jingxi Wang, et al.
Published: (2025-04-01)

Editorial: Women in renal pharmacology 2023
by: Nuria Lloberas, et al.
Published: (2025-01-01)

Editorial: Methods in experimental pharmacology 2023
by: Somasundaram Arumugam, et al.
Published: (2025-01-01)

Self-management and COPD: a qualitative study to explore the perceived barriers and recommendations to improve COPD management using the Information-Motivation-Behavioral skills model
by: Xiaomei Chen, et al.
Published: (2025-07-01)

Trends in initial pharmacological COPD treatment in primary care (2010–2021): a population-based study using the PHARMO Data Network
by: Guilherme Rodrigues, et al.
Published: (2024-12-01)

Machine learning assisted immune profiling of COPD identifies a unique emphysema subtype independent of GOLD stage
by: Natalie Bordag, et al.
Published: (2025-07-01)

Relationships between vitamin C intake and COPD assessed by machine learning approaches from the NHANES (2017–2023)
by: Xinxin Tao, et al.
Published: (2025-05-01)

Treatment strategy for fatigue in rheumatic diseases in view of the 2023 EULAR recommendations
by: E. S. Aronova, et al.
Published: (2024-06-01)

Exploring the Mechanisms of Lijin Fang on Treg/Th17 Cell Imbalance in COPD Based on Network Pharmacology
by: Li ZH, et al.
Published: (2025-07-01)

Correction: Trends in initial pharmacological COPD treatment in primary care (2010–2021): a population-based study using the PHARMO Data Network
by: Guilherme Rodrigues, et al.
Published: (2025-08-01)

European osteoporosis pharmacological guidelines confirm current recommended treatment whilst answering important management questions
by: H. de Wet
Published: (2019-12-01)

Editorial: Model organisms in respiratory pharmacology 2023
by: Alexandra McCarron, et al.
Published: (2025-01-01)

The Association Between COPD, Acute Exacerbations of COPD, and Survival in COPD, with Fat-Free Body Mass Index: A Systematic Review and Meta-Analysis
by: Hu C, et al.
Published: (2025-07-01)

Mortality and exacerbation risk according to GOLD and STAR severity stages of COPD: a 5-year multicenter prospective cohort study
by: Hiroaki Ogata, et al.
Published: (2025-05-01)

Oral Corticosteroid Use and the Risk of Acute Myocardial Infarction in Chronic Obstructive Pulmonary Disease
by: Laetitia Huiart, et al.
Published: (2006-01-01)

Rates and Patterns of Chronic Obstructive Pulmonary Disease Exacerbations
by: Magda Nunes de Melo, et al.
Published: (2004-01-01)

Echocardiographic Evidence of Left Ventricular Dysfunction in COPD: Relationship with Disease Severity
by: Rounak Bhattacharjee, et al.
Published: (2025-07-01)

Estimating the prevalence of COPD in an African country: evidence from southern Nigeria
by: Boni M. Ale, et al.
Published: (2022-09-01)

Optimizing Treatment for Hospitalized Patients with COPD: A Study on the Impact of a LINE App-Based Multidisciplinary Team Approach Targeting Pharmacological Treatment, Lifestyle Changes, and Smoking Cessation
by: Huang HY, et al.
Published: (2025-04-01)

Associations between TLRs 2 and 4, and β-lactam antibiotics in COPD patients complicated with pulmonary infections
by: Yunchen Lou, et al.
Published: (2024-06-01)

Systematic Review on Influenza Burden in Emerging Markets in 2018–2023—An Evidence Update to Guide Influenza Vaccination Recommendations
by: Moe H. Kyaw, et al.
Published: (2024-11-01)